Role of a combined soluble interleukine-2 receptor alpha (sIL-R2α) and CA-125 serum marker assay for detection of ovarian cancer

Altman, A., Mustelin, T., Coggeshall, K.M. (1990). T lymphocyte activation: A biological model of signal transduction. Crit. Rev. Immunol., 10, 347-391.Search in Google Scholar

Barton, D.P., Blanchard, D.K., Michelini-Norris, B., Nicosia, S.V., Cavanagh, D., Djeu, J.Y. (1993). High serum and ascitic soluble interleukin-2 receptor α levels in advanced epithelial ovarian cancer. Blood, 81(2), 424-429.10.1182/blood.V81.2.424.424Search in Google Scholar

Bien, E., Rapala, M., Krawczyk, M., Balcerska, A. (2010). The serum levels of soluble interleukin-2 receptor alpha and lactate dehydrogenase but not of B2-microglobulin correlate with selected clinico-pathological prognostic factors and response to therapy in childhood soft tissue sarcomas. J. Cancer Res. Clin. Oncol., 136(2), 293-305.10.1007/s00432-009-0661-xSearch in Google Scholar

Bruijn, H.W., ten Hoor, K.A., van der Zee, A.G. (1998). Serum and cystic fluid levels of soluble interleukin-2 receptor-alpha in patients with epithelial ovarian tumors are correlated. Tumour Biol., 19(3), 160-166.10.1159/000030003Search in Google Scholar

Brunetti, G., Bossi, A., Baiardi, P., Jedrychowska, I., Pozzi, U., Bacchella, L., Bernardo, G. (1999). Soluble interleukin 2 receptor (sIL2R) in monitoring advanced lung cancer during chemotherapy. Lung Cancer, 23, 1-9.10.1016/S0169-5002(98)00094-4Search in Google Scholar

Chilosi, M., Semenzato, G., Cetto, G., Ambrosetti, A., Fiore-Donati, L., Perona, G., Berton, G., Lestani, M., Scarpa, A., Agostini, C. (1987). Soluble interleukin-2 receptors in the sera of patients with hairy cell leukemia: Relationship with the effect of recombinant α-interferon therapy on clinical parameters and natural killer in vitro activity. Blood, 70(5), 1530-1535.10.1182/blood.V70.5.1530.1530Search in Google Scholar

Ferdeghini, M., Gadducci, A., Prontera, C., Malagnino, G., Fanucchi, A., Annicchiarico, C., Facchini, V., Bianchi, R. (1993). Serum soluble interleukin-2 receptor assay in epithelial ovarian cancer. Tumour Biol., 14(5), 303-309.10.1159/000217843Search in Google Scholar

Gebauer, G., Rieger, M., Jäger, W., Lang, N. (1999). Prognostic relevance of soluble interleukin-2 receptors in patients with ovarian tumors. Anticancer Res., 19(4A), 2509-2511.Search in Google Scholar

Hunter, V.J., Weinberg, J.B., Haney, A.F., Soper, J.T., Lavin, P., Metsch, L., Knapp, R.C., Bast, R.C. (1990). CA 125 in peritoneal fluid and serum from patients with benign gynecologic conditions and ovarian cancer. Gynecol Oncol., 36(2), 161-165.10.1016/0090-8258(90)90165-HSearch in Google Scholar

Hurteau, J.A., Woolas, R.P., Jacobs, I.J., Oram, D.C., Kurman, C.C., Rubin, L.A., Nelson, D.L., Berchuck, A., Bast, R.C., Mills, G.B. (1995). Soluble interleukin-2 receptor alpha is elevated in sera of patients with benign ovarian neoplasms and epithelial ovarian cancer. Cancer, 76(9), 1615-1620.10.1002/1097-0142(19951101)76:9<1615::AID-CNCR2820760918>3.0.CO;2-GSearch in Google Scholar

Jo, S.A., Hwang, S.H., Chang, C.L., Kim, S.Y., Shin, H.J., Chung, J.S., Sol, M.Y., Lee, E.Y. (2010). Clinical relevance of elevated levels of serum soluble interleukin-2 receptor alpha (sIL-2Rα) in patients with non-Hodgkin's lymphoma. Korean J. Lab. Med., 30(6), 600-605.10.3343/kjlm.2010.30.6.600Search in Google Scholar

Lauria, F., Rondelli, D., Raspadori, D., Zinzani, P.L., Benfenati, D., Pileri, S., Sabattini, E., Tura, S. (1992). Serum soluble interleukin-2 receptor levels in hairy cell leukemia: Correlation with clinical and hematological parameters and with alpha-interferon treatment. Leuk. Lymphoma, 7(1-2), 103-107.10.3109/10428199209053608Search in Google Scholar

Lissoni. P., Barni, S., Rovelli, F., Viviani, S., Maestroni, G.J., Conti, A., Tancini, G. (1990). The biological significance of soluble interleukin 2 receptors in solid tumors. Eur. J. Cancer, 26, 33-36.10.1016/0277-5379(90)90253-PSearch in Google Scholar

Meyer, F., Samson, E., Douville, P., Duchesne, T., Liu, G., Bairati, I. (2010). Serum prognostic markers in head and neck cancer. Clin. Cancer Res., 16(3), 1008-1015.10.1158/1078-0432.CCR-09-2014Search in Google Scholar

Mills, G.B., Zhang, N., Schmandt, R., Fung, M., Greene, W., Mellors, A., Hogg, D. (1991). Transmembrane signalling by interleukin-2. Biochem. Soc. Trans., 19, 277-285.10.1042/bst0190277Search in Google Scholar

Owens, O.J., Taggart, C., Wilson, R., Walker, J.J., McKillop, J.H., Kennedy, J.H. (1993). Interleukin-2 receptor and ovarian cancer. Brit. J. Cancer, 68, 364-367.10.1038/bjc.1993.341Search in Google Scholar

Pavlidis, N.A., Bairaktari, E., Kalef-Ezra, J., Nicolaides, C., Seferiadis, C., Fountzilas, G. (1995). Serum soluble interleukin-2 receptors in epithelial ovarian cancer patients. Int. J. Biol. Markers, 10(2), 75-80.10.1177/172460089501000202Search in Google Scholar

Rubin, L.A., Kurman, C.C., Fritz, M.E., Biddison, W.E., Boutin, B., Yarchoan, R., Nelson, D.L. (1985). Soluble interleukin-2 receptors are released from activated human lymphoid cells in vitro. J. Immunol., 135, 3172-3175.Search in Google Scholar

Rubin, L.A., Nelson, D. (1990). The soluble interleukin-2 receptor: Biology, function and clinical application. Ann. Intern. Med., 113, 619-645.10.7326/0003-4819-113-8-619Search in Google Scholar

Sedlaczek, P., Frydecka, I., Gabryś, M., Van Dalen, A., Einarsson, R., Harłozińska, A. (2002). Comparative analysis of CA125, tissue polypeptide specific antigen, and soluble interleukin-2 receptor α levels in sera, cyst, and ascitic fluids from patients with ovarian carcinoma. Cancer, 95, 1886-1893.10.1002/cncr.10917Search in Google Scholar

Smith, K.A. (1988). Interleukin-2: Inception, impact and implications. Science, 240(4856), 1169-1176.Search in Google Scholar

Sperner-Unterweger, B., Neurauter, G., Klieber, M., Kurz, K., Meraner, V., Zeimet, A., Fuchs, D. (2011). Enhanced tryptophan degradation in patients with ovarian carcinoma correlates with several serum soluble immune activation markers. Immunobiology, 216(3), 296-301.10.1016/j.imbio.2010.07.010Search in Google Scholar

Symons, J.A., Wood, N.C., Di Giovine, F.S., Duff, G.W. (1988). Soluble IL-2 receptor in rheumatoid arthritis. Correlation with disease activity, IL-I and IL-2 inhibition. J. Immunol., 141(8), 2612-2618.Search in Google Scholar

Waldmann, T.A. (1991). The interleukin-2 receptor. J. Biol. Chem., 266, 2681-2684.10.1016/S0021-9258(18)49895-XSearch in Google Scholar